Compare TLF & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLF | QTTB |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 25.1M |
| IPO Year | N/A | N/A |
| Metric | TLF | QTTB |
|---|---|---|
| Price | $2.68 | $3.06 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.33 |
| AVG Volume (30 Days) | 14.0K | ★ 9.1M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | ★ 56.60% | N/A |
| EPS Growth | ★ 308.92 | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $74,550,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.26 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.56 | $1.35 |
| 52 Week High | $5.48 | $6.37 |
| Indicator | TLF | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 53.04 |
| Support Level | $2.60 | $2.83 |
| Resistance Level | $2.74 | $3.96 |
| Average True Range (ATR) | 0.08 | 0.35 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 39.68 | 25.00 |
Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, Canada and others and generates the highest revenue from the United States.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.